
SENVELGO® is an FDA-approved preparation containing SENVELGO, for veterinary use. Available by prescription.
How to Give Oral Solution
Oral solutions are liquid medications that you give by mouth. In a solution, the medication is completely dissolved in the liquid, so it usually looks clear or evenly colored. Here's how to give it:
Velagliflozin, commercially available as SENVELGO®, is a sodium-glucose cotransporter 2 (SGLT2) inhibitor utilized for feline glucose management. It is a prescription medication available as an oral solution for use in cats, requiring professional guidance and frequent monitoring by a licensed veterinarian. It is frequently considered in the context of diabetes mellitus for managing blood sugar levels in newly diagnosed feline patients.
The actions described here reflect the product's FDA-approved labeling; your veterinarian determines the appropriate use for your animal.
Prescription only. Use only under the direction of a licensed veterinarian. This information is not a substitute for veterinary diagnosis, prescribing or monitoring.
At a pharmacological level, it manages blood glucose by inhibiting glucose reabsorption in the kidneys, offers an approach to the excretion of excess sugar through the urine. Commonly observed effects include localized digestive changes such as diarrhea or vomiting and behavioral shifts like lethargy. A high-priority clinical consideration is the risk of diabetic ketoacidosis (DKA); your veterinarian will monitor for observational signs of ketones through regular testing. Owners should monitor for significant changes in appetite or energy and contact their veterinarian immediately.
Yes. SENVELGO® is a prescription medication and requires a valid authorization from a licensed veterinarian. Mixlab verifies all legal requirements before any medication is shipped.
Veterinarians discuss SENVELGO® because it is a once-daily oral solution that is used in the context of managing blood sugar without injections. It is typically considered for cats who have not previously been managed with insulin.
Your veterinarian will recommend frequent monitoring of blood glucose and ketones, especially when first starting. This monitoring ensures the management approach remains safe and suitable for your cat.
Important observational signs include persistent vomiting, weakness or a decrease in appetite. If you notice these shifts, contact your veterinarian immediately for a clinical review of the protocol.
SENVELGO® is typically authorized for cats who are not insulin-dependent. Your veterinarian will determine the most suitable clinical approach based on your cat's specific diagnostic history.